The medical device maker is generating significantly higher returns from its existing capital base, signaling improved operational efficiency and a potentially undervalued stock.
Shares of firearms manufacturer Smith & Wesson have surged over 45% in six months, hitting a new 52-week peak following solid Q3 results. But beneath the headline momentum, analysts point to concerning long-term trends in sales, cash flow, and returns that could give investors pause.
In a notable shift from typical FTSE ownership patterns, individual investors now control half of London's historic pub operator Fuller, Smith & Turner. The structure raises questions about governance and future strategy for the 177-year-old business.
As the third-quarter earnings season wraps up, we examine the performance of key players in the leisure products sector, from firearms to outdoor gear and golf equipment, revealing a mixed bag of results and market reactions.
Central Garden & Pet reported mixed fourth-quarter results, with revenue falling short of Wall Street forecasts as strategic portfolio optimization weighed on sales. However, disciplined cost control and a focus on higher-margin categories drove a significant earnings beat.
A. O. Smith delivered robust margin expansion in Q4, driven by its commercial and water treatment segments, even as sales remained flat year-over-year. We delve into the key questions from analysts that cut to the heart of the company's future challenges and opportunities.
The Smithsonian's National Zoo in Washington, D.C., celebrates the historic arrival of a female Asian elephant calf, marking a significant milestone for the endangered species' conservation and inviting the public to help choose her name.
A.O. Smith's Q4 2025 earnings reveal a tale of two stories: revenue that missed expectations but profits that beat them. The water technology leader is leaning into commercial strength and operational discipline to expand margins, even as it braces for a challenging 2026 marked by input cost inflation and persistent softness in its China business.
Stanley Black & Decker reported a mixed 2025, highlighting strong margin improvement and cash flow but facing volume declines. As the company navigates tariff impacts and executes strategic divestitures, its 2026 outlook hinges on brand revitalization and disciplined cost management.
Sullivan & Cromwell advised on the highest-value deals in the consumer sector last year, while Kirkland & Ellis worked on the greatest number of transactions, according to new data from GlobalData.
Marsh & McLennan's robust Q4 results, driven by strategic investments and digital transformation, set the stage for pointed analyst inquiries on AI integration, margin resilience, and the path for sustained growth in a challenging market.
Investment bank Moelis & Company outperformed analyst expectations for Q4 2025, reporting an 11.2% year-over-year revenue increase to $487.9 million. The firm credits robust dealmaking, a record capital markets year, and strategic hiring for its momentum.
Stanley Black & Decker's Q4 2025 earnings reveal a tale of two metrics: profits beat expectations through disciplined cost control, while revenue flatlined amid soft consumer demand. The company's strategic pivot focuses on profitability over pure sales volume.
As Marsh & McLennan shares show mixed signals with a recent rebound but a sharp annual decline, investors are grappling with conflicting valuation metrics. While one model suggests a significant discount, traditional price-earnings analysis paints a different picture, highlighting the complexity of pricing the insurance brokerage giant in today's market.
Moelis & Co's stock has faced significant headwinds over the past year, declining over 7%. While its long-term performance remains robust, recent weakness prompts a closer look at its valuation through multiple lenses—from excess returns to P/E ratios—to determine if the market has overcorrected.
Buoyed by a surge in M&A and capital markets activity, investment bank Moelis & Company reported record quarterly and annual revenues for 2025. Executives point to a strengthened talent bench and improving operating leverage as catalysts for momentum heading into what they forecast will be a robust year for transactions.
IDEX Corporation capped off fiscal 2025 with stronger-than-anticipated fourth-quarter results, propelled by a record-setting order surge in its Health & Science Technologies unit linked to data center and AI infrastructure. While management expressed confidence in its strategic evolution, it offered a measured outlook for the coming year amid a mixed industrial landscape.
Comfort Systems USA is positioning for growth with a record project backlog, strategic acquisitions in AI infrastructure, and a significant dividend increase, as it prepares for inclusion in the S&P 500 index in late 2025.
While WH Smith's shares have seen an 11% uptick recently, long-term investors are grappling with a 59% plunge over three years. We examine the underlying business performance, insider sentiment, and whether this signals a fragile turnaround or deeper challenges.
While global markets present a mixed picture, Asia's technology sector remains a beacon for growth-focused investors. We examine three standout companies—T&S Communications, Dexerials, and Kohoku Kogyo—that are navigating economic shifts with innovation and strategic agility, offering compelling prospects in the region's dynamic tech landscape.
